UBI HIV gp120

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameUBI HIV gp120

Drug Alias NameHIV vaccine (United Biomedical)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionHIV envelope protein gp120 modulators

TargetsHIV envelope protein gp120

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUnited Biomedical Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUnited Biomedical Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A